GlassScriptPhysician profile
Noah John Hochendoner
NPI 1932723848
$33,526.28
in general payments reported to CMS, 2019-2025
24 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $380 · 2022: $504 · 2023: $1,217 · 2024: $15K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $5,635 · Food and Beverage: $3,576 · Honoraria: $1,540 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,863.35 |
| Travel and Lodging | $5,635.25 |
| Food and Beverage | $3,576.23 |
| Honoraria | $1,540.00 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $28,041.79 | 2022-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Lundbeck LLC | $2,960.63 | 2023-2024 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Abbvie INC. | $547.28 | 2023-2024 | |
| Axsome Therapeutics, INC. | $473.06 | 2022-2024 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $249.35 | 2022-2025 | Caplyta |
| Alkermes, INC. | $181.60 | 2022-2024 | Aristada, Lybalvi |
| Procept Biorobotics Corporation | $163.66 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $145.68 | 2022-2024 | Austedo Xr, Uzedy |
| Neurocrine Biosciences, INC. | $116.93 | 2022-2024 | Ingrezza |
| Medtronic, INC. | $116.72 | 2021 | |
| Idorsia Pharmaceuticals US INC | $94.60 | 2023 | Quviviq |
| Teleflex LLC | $87.94 | 2021 | |
| Janssen Pharmaceuticals, INC | $66.24 | 2023-2024 | Invega Sustenna |
| Takeda Pharmaceuticals U.S.A., INC. | $54.76 | 2022-2023 | Trintellix |
| Corium, LLC | $30.70 | 2024 | Azstarys |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $30.33 | 2022 | |
| Vanda Pharmaceuticals INC. | $30.04 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 2024 | Cobenfy |
| Neos Therapeutics, LP | $21.88 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $21.05 | 2024 | |
| Indivior INC. | $19.95 | 2022 | |
| Supernus Pharmaceuticals, INC. | $18.74 | 2024 | Qelbree |
| Noven Therapeutics, LLC | $14.52 | 2022 | |
| Astellas Pharma US INC | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Hochendoner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.